SCHEMBL10198751

SCHEMBL10198751

C=C/C=C(N)\C=C/N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13515547 1.00
SCHEMBL13593651 0.77
SCHEMBL18570000 0.74
SCHEMBL328156 0.74
SCHEMBL12352915 0.74
SCHEMBL13370450 0.74
SCHEMBL19889715 0.72
SCHEMBL463777 0.71
SCHEMBL24351362 0.71
SCHEMBL20835246 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239750-A1 BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS C4 THERAPEUTICS, INC. (US) 2023-12-14 WO disclosed
EP-3392252-B1 PYRIMIDO- PYRIDAZINONE COMPOUNDS AND USE THEREOF LIBERTAS BIO INC (US) 2023-10-04 EP disclosed
WO-2016003450-A1 PKC-EPSILON INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-01-07 WO disclosed
US-20120316359-A1 Biological Buffers with Wide Buffering Ranges TPAT IP LLC 2012-12-13 US disclosed
WO-2011101069-A2 HETARYLAMINONAPHTHYRIDINES MERCK PATENT GMBH (DE) 2011-08-25 WO disclosed
WO-2007051065-A2 COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE NUMERATE, INC. (US) 2007-05-03 WO disclosed